OTCMKTS:VICA

Rafina Innovations Stock Forecast, Price & News

$0.05
0.00 (0.00 %)
(As of 06/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.05
▼
$0.06
50-Day Range
$0.04
▼
$0.22
52-Week Range
$0.02
▼
$0.40
Volume26,364 shs
Average Volume251,247 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive VICA News and Ratings via Email

Sign-up to receive the latest news and ratings for Rafina Innovations and its competitors with MarketBeat's FREE daily newsletter.


About Rafina Innovations

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

Headlines

Rafina Innovations Inc. (OTCMKTS:VICA) Sees Large Increase in Short Interest
Rafina Innovations Inc. (OTCMKTS:VICA) Sees Large Increase in Short Interest
May 29, 2021 |  americanbankingnews.com
Rafinas Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million
Rafina's Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million
May 25, 2021 |  finance.yahoo.com
Rafinas Subsidiary C-Pharm Ltd Total Sales for 2020 $2.7 Million
Rafina's Subsidiary C-Pharm Ltd Total Sales for 2020 $2.7 Million
May 18, 2021 |  finance.yahoo.com
Rafina Innovations Inc.
Rafina Innovations Inc.
May 14, 2021 |  barrons.com
‘Nordstrom’s best-kept secret’: These leggings are now less than $8
‘Nordstrom’s best-kept secret’: These leggings are now less than $8
April 24, 2021 |  au.finance.yahoo.com
Rafina Innovations Inc (VICA)
Rafina Innovations Inc (VICA)
August 7, 2020 |  nasdaq.com
Rafina Innovations Inc Comments on Recent Stock Volume and Price Increase
Rafina Innovations Inc Comments on Recent Stock Volume and Price Increase
February 27, 2019 |  finance.yahoo.com
Rafina Innovations Inc., Insider Buying, Share Consolidation and Recent News Could Put this one on Traders Radars
Rafina Innovations Inc., Insider Buying, Share Consolidation and Recent News Could Put this one on Traders Radars
February 25, 2019 |  finance.yahoo.com
Rafina Innovations Develops a Prototype Named Flexi Cuff for Deep Vein Thrombosis Patients
Rafina Innovations Develops a Prototype Named Flexi Cuff for Deep Vein Thrombosis Patients
February 25, 2019 |  finance.yahoo.com
Rafina Innovations Begins Development on a Prototype for Sleep Apnoea
Rafina Innovations Begins Development on a Prototype for Sleep Apnoea
February 14, 2019 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.38 out of 5 stars

Medical Sector

1828th out of 2,105 stocks

Medical Devices Industry

17th out of 22 stocks

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Rafina Innovations (OTCMKTS:VICA) Frequently Asked Questions

What stocks does MarketBeat like better than Rafina Innovations?

Wall Street analysts have given Rafina Innovations a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Rafina Innovations wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Rafina Innovations?

Rafina Innovations saw a increase in short interest during the month of May. As of May 14th, there was short interest totaling 400 shares, an increase of 100.0% from the April 29th total of 200 shares. Based on an average trading volume of 437,800 shares, the days-to-cover ratio is currently 0.0 days.
View Rafina Innovations' Short Interest.

How has Rafina Innovations' stock been impacted by Coronavirus (COVID-19)?

Rafina Innovations' stock was trading at $0.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VICA shares have decreased by 23.6% and is now trading at $0.0535.
View which stocks have been most impacted by COVID-19.

Who are Rafina Innovations' key executives?

Rafina Innovations' management team includes the following people:
  • Mr. Constantinos Zertalis, Chairman, Pres & CEO (Age 43)
  • Mr. Nikolaos Kardaras, Head of Legal Department (Age 71)
  • Ms. Paraskevi Pilarinou, Financial Controller
  • Ms. Paraskevi Pylarinou, CFO, Sec. & Director (Age 33)
  • Dr. Hari Elangovan, Acting Chief Technology Officer
  • Ms. Evaggelia Moschidou, Marketing Director
  • Prof. Stephan Solomonidis, Head of Research
  • Mr. Georgios Thrapsaniotis, Treasurer & Director (Age 76)
  • Mr. Yiannis Levantis, Independent Technology Advisor & Director (Age 45)

Who are some of Rafina Innovations' key competitors?

Some companies that are related to Rafina Innovations include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of VICA's competitors.

What other stocks do shareholders of Rafina Innovations own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rafina Innovations investors own include Ascent Solar Technologies (ASTI), HTG Molecular Diagnostics (HTGM), (FLTX) (FLTX), CV Sciences (CVSI), American Lithium (LI), LightPath Technologies (LPTH), Natural Alternatives International (NAII), SCANA (SCG), Emerald Health Therapeutics (EMHTF) and Cisco Systems (CSCO).

What is Rafina Innovations' stock symbol?

Rafina Innovations trades on the OTCMKTS under the ticker symbol "VICA."

How do I buy shares of Rafina Innovations?

Shares of VICA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rafina Innovations' stock price today?

One share of VICA stock can currently be purchased for approximately $0.05.

How many employees does Rafina Innovations have?

Rafina Innovations employs 4 workers across the globe.

What is Rafina Innovations' official website?

The official website for Rafina Innovations is www.hciviocare.com.

Where are Rafina Innovations' headquarters?

Rafina Innovations is headquartered at Kintyre Hse, 209 Govan Road, GLASGOW, G51 1HJ, United Kingdom.

How can I contact Rafina Innovations?

Rafina Innovations' mailing address is Kintyre Hse, 209 Govan Road, GLASGOW, G51 1HJ, United Kingdom. The company can be reached via phone at 441413700321.


This page was last updated on 6/23/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.